NAD injections: is the science actually missing, or just misread?

What's this video probably claiming?

Based on the caption and hashtag pattern, @mayzo_47 appears to have tried NAD+ injections, possibly alongside NMN or NR supplements, and concluded that the research base is too thin to justify continuing. The creator seems to be positioning this as a responsible pullback, not a scare story. That framing is worth taking seriously, because it's partially right and partially a misread of where the science actually stands. The video likely touches on personal side effects or a lack of noticeable results, combined with a general skepticism about the longevity supplement space. Given the TRT category tag, there may also be a thread about whether NAD+ supplementation stacks with hormone optimization protocols, which is a topic circulating in men's health communities right now. The creator's decision to walk away from the entire category, including patches, oral NMN, and NR, suggests they're not just critiquing injections but the whole NAD precursor market.

What does the science actually show?

The honest answer is that NAD+ research is real, but most of the compelling data is preclinical. In animal models, NAD+ repletion via NMN or NR has shown improvements in muscle function, metabolic markers, and mitochondrial health (Yoshino et al., 2018, Cell Metabolism). Human trials exist but are smaller and shorter than the hype implies. A 2022 randomized controlled trial by Yoshino et al. published in Science found that NMN supplementation in postmenopausal women improved muscle insulin sensitivity at 250 mg per day over 10 weeks, but did not significantly change body composition or energy levels. A 2023 trial by Yi et al. in GeroScience tested NMN at 300 mg and 600 mg daily and found modest improvements in muscle strength in older adults. Injectable NAD+ specifically has almost no controlled human trial data. What exists are case reports, practitioner observations, and lab-measured NAD+ level changes. The gap between animal data and human clinical outcomes is where the creator's skepticism has a legitimate foothold.

Where does the social media noise diverge from clinical reality?

TikTok's NAD+ content tends to skip straight to outcomes: better skin, more energy, anti-aging effects, cognitive clarity. The hashtag skintok appearing here is telling. NAD+ has been framed as a skin supplement partly because sirtuins, proteins that NAD+ activates, play a role in DNA repair and inflammation pathways. But no human trial has demonstrated that NAD+ injections improve skin appearance at a clinically measurable level. That's not a minor gap. The biohacking community has conflated mechanistic plausibility with proven benefit, which is a consistent problem. On the TRT side, there's emerging interest in whether NAD+ supports testosterone metabolism or Leydig cell function, but this is speculative. A 2021 review in Aging Research Reviews noted that NAD+ depletion correlates with age-related hormonal changes, but correlation is not a treatment signal. Practitioners pairing NAD+ with TRT protocols are working from hypothesis, not controlled evidence. The creator walking away from all of it is understandable, even if the reasoning may be slightly overcorrected.

What should you actually know?

NAD+ precursors are not fraudulent supplements, but they are not proven therapeutics either. The injection format is the least studied delivery method. Oral NMN and NR have more human data, though even that data is preliminary and not sufficient to make strong clinical recommendations. If a provider is selling NAD+ injections as an anti-aging treatment or as an adjunct to TRT without disclosing the limited evidence base, that's a problem worth naming. The FDA has not approved any NAD+ product for any indication. Compounded NAD+ injections exist in a gray regulatory space, and quality control varies significantly between compounding pharmacies. Patients considering any NAD+ protocol should ask their provider for the specific evidence supporting their recommendation, not just general longevity research. The creator's instinct to pause and ask whether harm is possible is a reasonable clinical reflex. The research isn't absent, but it's not where the marketing suggests it is.